Skip to main content
OpenTrials

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,810 public trials 85 recruiting studies
Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

NCT05028361

Conditions
Adverse Drug Event, COVID-19, Chemically-Induced Disorders, +20 more
Locations
  • John Hopkins University Baltimore, Maryland, United States
  • Duke University Durham, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

NCT01006798

Conditions
Animal Diseases, Bird Diseases, Bird Flu, +9 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • The Center for Pharmaceutical Research Kansas City, Missouri, United States
  • University of Rochester Rochester, New York, United States
  • Coastal Carolina Research Center, Inc. Mt. Pleasant, South Carolina, United States
View Trial Details
Completed

Performance Evaluation of the Lucira COVID-19 & Flu Test

NCT06141824

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Benchmark Research Colton, California, United States
  • Carbon Health Oakland, California, United States
  • Koch Family Medicine Morton, Illinois, United States
View Trial Details
Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23

NCT05568979

Conditions
Infections, Influenza (Healthy Volunteers), Influenza, Human, +5 more
Locations
  • Investigational Site Number : 2-2-002 Helsinki, Finland
  • Investigational Site Number : 2-2-005 Jyväskylä, Finland
  • Investigational Site Number : 2-2-004 Kuopio, Finland
  • Investigational Site Number : 2-2-006 Rauma, Finland
View all 15 locations
View Trial Details
Completed

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

NCT04669691

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • 23302- Al Mare Perearstikeskus OÜ Tallinn, Harju, Estonia
  • 23301- Clinical Research Center Tartu, Estonia
  • 60805 - De La Salle Medical and Health Sciences Institute Dasmariñas, Manila, Philippines
  • 60804 - University of Perpetual Help Dalta Medical Center Las Piñas, Manila, Philippines
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

NCT05052697

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • North Alabama Research Center Athens, Alabama, United States
  • The Heart Center Athens, Alabama, United States
  • Arizona Heart Rhythm Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
View all 100 locations
View Trial Details

Related conditions